Delivery Order SPE2DE24DA010-SPE2D626F27NB
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $28,350 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment is scheduled for completion by January 20, 2026, and will be performed in Santa Clara, California. The delivery order carries no set-aside designation and was awarded through full and open competition, reflecting Abbott's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 on November 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment is scheduled for completion by December 2, 2025, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation, consistent with Abbott Vascular's established competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $17,803.40 on January 9, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment authority is scheduled for ultimate completion by January 14, 2026, and will be performed in Santa Clara, California. The award was made through full and open competition with no set-aside designation, reflecting Abbott's competitive...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on January 20, 2026, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by January 23, 2026, and will be performed at Abbott's location in Santa Clara, California. This award represents a task order issued under the Defense Logistics Agency's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $5,695.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes a fixed-price structure with economic price adjustment pricing and was awarded without a set-aside designation through full and open competition. Performance will take place in Santa Clara, California, positioning the award...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $26,480.13 by the Defense Logistics Agency's Medical Supply Chain on December 1, 2025, with an ultimate completion date of December 4, 2025. This fixed-price delivery order with economic price adjustment carries no set-aside designation and will be performed in Santa Clara, California. The award represents a task order under Abbott's established relationship with the Defense Logistics...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $24,350 from the Defense Logistics Agency Medical Supply Chain on December 18, 2025, with an ultimate completion date of December 23, 2025. The contract employs a fixed-price structure with economic price adjustment terms and carries no set-aside designation, reflecting full and open competition. Performance will occur at Abbott Vascular's Santa Clara, California location. This delivery...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc.'s Abbott Vascular division was awarded a delivery order valued at $5,695 on December 11, 2025, under a Defense Logistics Agency Medical Supply Chain contract. This fixed-price delivery order with economic price adjustment authority is scheduled for completion by January 6, 2026, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. This delivery order represents a task order draw against Abbott's...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D626F27NBDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $5,695.00 on January 26, 2026, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price contract with economic price adjustment will be performed in Santa Clara, California, with an ultimate completion date of January 29, 2026. The award was made through full and open competition with no set-aside designation, reflecting Abbott's established competitive positioning as a supplier of cardiovascular medical technologies to federal healthcare systems. This delivery order represents a task order issued against Abbott Vascular's broader indefinite delivery contract with the Defense Logistics Agency, which is valued at $117.1 million and provides comprehensive cardiovascular procedural packages including devices, instrumentation, accessories, and related medical technologies. Abbott Vascular has established itself as a critical supplier to the Department of Defense and Department of Veterans Affairs through multiple procurement vehicles, providing advanced cardiovascular implants such as stents, pacemakers, heart valves, and left ventricular assist devices that support complex medical procedures across military and veteran healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 1/25/26 |